NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









RevolKa Ltd.

RevolKa Ltd.

Private
SendaiHealthcare & Life Scienceshttps://www.revolka.com/

Last Round

Series A

Extension

Aug 18, 2025

Total Funding Raised

$12.06M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RevolKa Ltd. is a biotechnology company that provides an AI-driven protein engineering technology platform called aiProtein® to create novel proteins for therapeutics and industrial applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

protein engineeringantibody optimizationdrug discoveryin silico designbiologics developmentai drug discoverydirected evolutionsequence optimizationbiotech platformprotein designgenerative biologycontract researchindustrial enzymesCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RevolKa Ltd. Comparables

Compare RevolKa Ltd. with similar companies based on industry and business-model similarity.

RevolKa Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

RevolKa Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionAug 18, 2025
DebtJul 31, 2025
Series A ExtensionMay 20, 2025
Series A ExtensionAug 30, 2024
Series A ExtensionFeb 1, 2024
Series A
May 31, 2022

Key People

Founding team and executive leadership

Norio H.

President CEO

Executive Team

RevolKa Ltd. Investors

Notable investors and investment history

RevolKa Ltd. investors
InvestorRounds
七十七キャピタル株式会社Series A Extension
DEEPCORE Inc.Series A Extension
Tohoku University Venture PartnersSeed, Series A, Series A Extension
スパークル株式会社Seed
The 77 Bank, Ltd.Debt
SBI Investment Co., Ltd.Series A
D3 LLCSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 317% MoM to 21.8K.

  • Sep 9, 2025

    Exhibiting at Antibody Engineering 2025 in Amsterdam, September 9-10, 2025.

RevolKa Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RevolKa Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RevolKa Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSendai
Employee Range11
Year Founded2021
Last FundingAug 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.